Previous studies, although heterogeneous for screening methods, diagnostic criteria for GDM, blood glucose thresholds, glycemic control standards, and population characteristics, investigated the risk of insulin treatment in pregnant women with GDM [34–38]. The gene discussed is INS; the disease is gestational diabetes.